Longevity Biotechnology Grant
We provide small fast grants to visionary scientists and entrepreneurs working on groundbreaking innovations in longevity biotechnology. These grants are designed to quickly support and launch new ideas and projects, acting as a financial launchpad that de-risks early-stage projects often overlooked by legacy funders.
Focus Areas
- AI R&D: accelerating scientific discovery, research, and lab work through the application of AI, Digital Twin models, and automation tools.
- Extra cellular matrix (ECM): maintaining or improving ECM health for healthy aging.
- Exosomes: exosomes for tissue repair, drug delivery, and other longevity interventions.
- Gene therapy: developing scalable gene therapy vectors and pioneering novel delivery vehicles.
- Healthcare 3.0: advancing biomarker analysis and scalable personal longevity approaches.
- Reversible biostasis: pioneering new approaches to reversible biological preservation.
- Replacement: developing organ, brain, 3D organoid technology, and whole body replacement approaches.
- Mapping novel opportunities: proposals that map and scope novel, undervalued opportunities within a given field.
Fast grant: longevity biotechnology
Longevity biotechnology has the potential to stop aging, diminish age-related diseases like cancer and heart disease, and extend healthy lives. To accelerate progress, we offer fast grants – smaller and with short review times – to quickly test promising ideas. Our focus is on projects that can help achieve longevity escape velocity (LEV) – improving life expectancy at a faster rate than people are aging.
Healthcare that is focused on preventing and reversing aging would not only diminish the pains of age-related disease, but also enable people to live healthy lives for as long as they choose. We also see functional cryonics as an alternative path toward that same goal.
Focus areas
Areas we fund include but are not limited to:
- AI R&D: Accelerating scientific discovery, research, and lab work through the application of AI, Digital Twin models, and automation tools.
- Extra cellular matrix (ECM): maintaining or improving ECM health for healthy aging.
- Exosomes: exosomes for tissue repair, drug delivery, and other longevity interventions.
- Gene therapy: developing scalable gene therapy vectors and pioneering novel delivery vehicles.
- Healthcare 3.0: advancing biomarker analysis and scalable personal longevity approaches.
- Reversible biostasis: pioneering new approaches to reversible biological preservation.
- Replacement: developing organ, brain, 3D organoid technology, and whole body replacement approaches.
- Mapping novel opportunities: proposals that map and scope novel, undervalued opportunities within a given field.
These focus areas are influenced by Convergent Research’s Gap Map, the Amaranth’s Bottlenecks of Aging Roadmap and the LBF Roadmap.
How to apply?
Fill out the form at the top of this page to apply. Applications are reviewed once per quarter, with deadlines of:
- March 31st
- June 30th
- September 30th
- December 31st
We work to keep the review process efficient and minimal. If required, we may follow up with questions or arrange a brief screening call.
Funding and terms
- We focus on initiatives where a small grant of around $10,000 can effectively de-risk an idea, kickstart a project, or explore a new path to impact.
- We aim to make decisions within two weeks after the application deadline. However, timelines may vary based on project specifics or other factors. If there are any delays or additional steps required, we’ll inform you promptly.
- We accept applications from individuals, teams, and organizations. Both non-profit and for-profit organizations are welcome to apply, but for-profits should be prepared to motivate why they need grant funding.
- We typically encourage open sharing of results, unless confidentiality is required.
How do we evaluate projects?
Projects are evaluated by Foresight staff and, when appropriate, external advisors. Our focus is on high-risk, high-reward projects that, while speculative, hold the potential to make significant advancements.
Further questions or feedback?
Please reach out to [email protected]
About fast grants
Traditional funding often overlook early-stage, high-potential projects. Inspired by the fast grants model pioneered by Impetus Grants, our aim with these grants is to change that. Many projects require as little as $10,000 to get started, yet they often fall outside the strict topical or operational criteria of traditional funders. Just as importantly, timely action is critical: promising ideas are too often delayed by lengthy application procedures and bureaucratic hurdles. Our grants exist to remove these barriers and help new projects launch quickly.
Advisors

John Hallman
OpenAI

Mark Hamalainen
ARPA-H

Philip Shiu
Eon Systems PBC